Phaxiam Therapeutics Sa logo

Phaxiam Therapeutics Sa Share Price (NASDAQ: PHXM)

▲

-3.1

(-100%)

Live

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 8 Mar 2024

Check the interactive Phaxiam Therapeutics Sa Stock chart to analyse performance

Phaxiam Therapeutics Sa Key Stats

Check Phaxiam Therapeutics Sa key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$3.1
Open
$3.06
Market Capitalization
$28.9M
Today's Volume
$902.0
Revenue TTM
$6.0M
EBITDA
$-16.9M
Earnings Per Share (EPS)
$-39.05
Profit Margin
-190.98%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-38.62%

Analyst Recommendation on Phaxiam Therapeutics Sa Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Phaxiam Therapeutics Sa(by analysts ranked 0 to 5 stars)

About Phaxiam Therapeutics Sa

PHAXIAM Therapeutics S.A., a biopharmaceutical company, focuses on developing treatments for resistant bacterial infections in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing a portfolio of phages targeting resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections, including staphylococcus aureus, escherichia coli, and pseudomonas aeruginosa. The company was formerly known as ERYTECH Pharma S.A. and changed its name to PHAXIAM Therapeutics S.A. in June 2023. PHAXIAM Therapeutics S.A. was incorporated in 2004 and is headquartered in Lyon, France.
Organization
Phaxiam Therapeutics Sa
Employees
49
CEO
Mr. Eric Soyer Ph.D.
Industry
Miscellaneous

Important FAQs about investing in PHXM Stock from India :

What is Phaxiam Therapeutics Sa share price today?

Phaxiam Therapeutics Sa share price today is as on . Phaxiam Therapeutics Sa share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Phaxiam Therapeutics Sa share?

Phaxiam Therapeutics Sa share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Phaxiam Therapeutics Sa stock price today i.e. is trending at , lower by 100% versus the 52 week high.

How to invest in Phaxiam Therapeutics Sa Stock (PHXM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Phaxiam Therapeutics Sa on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Phaxiam Therapeutics Sa Shares .

What is the minimum amount required to buy Phaxiam Therapeutics Sa Stock (PHXM) from India?

Indian investors can start investing in Phaxiam Therapeutics Sa (PHXM) shares with as little as ₹88.097 or $1 (as of September 18, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹880.97 in Phaxiam Therapeutics Sa stock (as per the Rupee-Dollar exchange rate as on September 18, 2025). Learn more about fractional shares .

What are the returns that Phaxiam Therapeutics Sa has given to Indian investors in the last 5 years?

Phaxiam Therapeutics Sa stock has given 0.0% share price returns and 19.79% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?